Zürich Metropolitan Area
I am a strategic, resourceful, results-oriented international executive with strong financial acumen and a passion to build teams and to deliver high impact strategic growth, business excellence, transformation, corporate development, and innovation initiatives. Across various roles, I have had P&L responsibility for USD 30 to 200 Million. I have a leadership track record of achievements in complex environments of international companies and research centers across pharmaceutical, biotechnology, chemicals, consumer goods, commodity, and pure research sectors. I value independent thinking, balanced decision making, and continuous learning, and have experience leading large cross-function teams, with and without direct authority by interpersonal influence. My skills include strategy, change management, finance, modelling, forecasting, Lean, Six Sigma, continuous improvement, risk management, capital expenditures, evaluation and execution of major investment portfolios, GMP and GLP quality management, analytics, digitalization, big data, machine learning, and artificial intelligence. I have extensive international experience especially in Asia, and I am proficient in 4 languages.
"The only place where Success comes before Value is in a dictionary." • Serve as a strategic partner to Lonza’s Executive Committee (EC) and CFO to identify and drive opportunities across all business platforms and modalities • EC Investment Committee member and coordinator with responsibility for Value delivery of a multi-Billion US$ portfolio of large growth and investment projects • Establish and maintain a pipeline of Value Creation Opportunities to achieve Lonza’s Full Potential • Executive sponsorship of the Lonza Business Management System (LBMS), a Lean-based operational excellence improvement program embedded in Lonza’s culture and throughout our global network of 30 sites • Drive high-impact strategic initiatives, including Lonza’s China Strategy
• Led strategic initiatives to drive profitable growth across all businesses during intense times of change, transformation and growth, reporting to three successive CEOs • Created and implemented Lean-based “Lonza Business Management System” with transformations, innovations, improvements yielding +US$ 100 million profit-level impact per annum • Drove priorities, engaged with senior stakeholders, fostered ownership within organization, facilitate collaborative efforts, and deliver outcomes through influence • Served as a trusted advisor to leadership, coaching and contributing to strategic decision making • Member of Lonza’s 12-member top leadership team, reporting to CEO
• Global business financial controller for worldwide network with sales of US$200 million: achieved substantial improvements in cost base, operating income • Led strategy, planning, and budget process with top management: achieved first ever above-budget-expectations results for business unit • Led due diligence and achieved successful integration of new acquisitions such as M-Scan (biopharmaceutical protein characterization), and Vitrology (bio-safety, virology, molecular biology) • Developed and deploy Life Science-oriented Corporate Security Risk assessment
• Led harmonized GMP quality management system for global network of 20 sites providing deep expertise in multiple areas of pharmaceutical manufacturing and clinical research • Achieved significant reduction in audit findings from customers and regulatory authorities • Led global program of risk-based quality assurance audits • Ensured compliance with regulatory authority requirements such as US FDA, MHRA, Swissmedic, etc. • Pioneered Lean-based operational excellence improvements in highly regulated environments
• Leader of Strategy and Continuous Improvement programs, created and led Lean-based operational excellence program for global network of more than 300 commercial testing laboratories for pharmaceutical, biotechnology, chemicals, consumer goods, agriculture, commodity industry sectors • Achieved more than US$25 Million of profitability improvements by leading 40 international performance improvement projects at prioritized sites in Asia Pacific, Europe, Africa, North and South America • Achieved massive scale-up and performance improvements across entire organization of 10 business divisions by training and coaching more than 300 top managers as Lean Leaders • Created and deployed forecasting models for global trade commodity businesses guiding data-driven executive decisions to maintain profitability during 2008 financial crisis
• Led three international teams conducting cutting-edge research and innovation including Higgs Boson searches with the Large Hadron Collider, a US$5 Billion research program at the world's largest and most respected physics research center • Achieved innovations and improvements saving years of cost- and manpower-intensive run time • Received prestigious CERN Research Fellowship (2001-2003), then Research Scientist with Brookhaven National Laboratory, based at CERN (2003-2005) • Supervised, mentored, coached research scientists and Ph.D. students
• Created innovative insight models across global initiatives: achieved growth in new client base • Assessed strategic global business opportunities for McKinsey • Consulted clients in Financial Services, Media, Entertainment sectors
Research focus areas included: • Electroweak symmetry breaking and Higgs Boson physics • Heavy quark physics • CP Violation/Matter-Antimatter asymmetries